|
XRCC6BP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.875200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.735900E-02 |
| Normal-vs-Stage2 |
2.579600E-01 |
| Normal-vs-Stage3 |
7.013000E-01 |
| Normal-vs-Stage4 |
6.999600E-02 |
| Stage1-vs-Stage2 |
9.642800E-01 |
| Stage1-vs-Stage3 |
3.410800E-01 |
| Stage1-vs-Stage4 |
2.037900E-02 |
| Stage2-vs-Stage3 |
4.801200E-01 |
| Stage2-vs-Stage4 |
3.813900E-02 |
| Stage3-vs-Stage4 |
7.486100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.718290E-02 |
| Normal-vs-AfricanAmerican |
3.571200E-01 |
| Normal-vs-Asian |
7.647200E-01 |
| Caucasian-vs-AfricanAmerican |
1.818580E-03 |
| Caucasian-vs-Asian |
1.655200E-01 |
| AfricanAmerican-vs-Asian |
8.609800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.890400E-02 |
| Normal-vs-Female |
2.892000E-01 |
| Male-vs-Female |
6.078400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.024160E-01 |
| Normal-vs-Extreme_Weight |
7.831800E-02 |
| Normal-vs-Obese |
3.173600E-01 |
| Normal-vs-Extreme_Obese |
1.750430E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.334600E-01 |
| Normal_Weight-vs-Obese |
4.918000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.958800E-01 |
| Extreme_Weight-vs-Obese |
3.735000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.354200E-01 |
| Obese-vs-Extreme_Obese |
6.116800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.581200E-01 |
| Normal-vs-Age(41-60Yrs) |
6.783000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.453600E-02 |
| Normal-vs-Age(81-100Yrs) |
7.208100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.559600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.618300E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.818300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.382300E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.695970E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.985600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.499800E-01 |
| Normal-VS-Type2 PRCC |
3.058200E-03 |
| Normal-VS-KIRP CIMP |
8.389800E-01 |
| Normal-VS-Unclassified PRCC |
3.788400E-02 |
| Type1 PRCC-VS-Type2 PRCC |
7.379500E-04 |
| Type1 PRCC-VS-KIRP CIMP |
6.991400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.724300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.435700E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.870200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.373590E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.598100E-02 |
| Normal-vs-N1 |
3.221200E-01 |
| Normal-vs-N2 |
8.184200E-01 |
| N0-vs-N1 |
1.602070E-02 |
| N0-vs-N2 |
3.666000E-01 |
| N1-vs-N2 |
7.863000E-01 |
|
|
